Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04861194 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)

Study acronym: ERECT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Aug 10, 2025 to Aug 10, 2027
    • Site details revised
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: May 18, 2023 to Aug 10, 2025
    • Study completion date: May 18, 2026 to Aug 10, 2025
    • Start date changed from estimate of May 18, 2021 to Jul 14, 2021
    • Site details revised
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UMC Utrecht
84 trials monitored
See all monitored trials
Prostate Cancer
2,546 trials monitored
See 172 trials at risk
Single-arm phase II trial of 70 men with low- or intermediate-risk prostate cancer receiving magnetic resonance guided adaptive radiotherapy (MRgRT) in 5 fractions of 7.25 Gy, additionally sparing the neurovascular bundles, the internal pudendal arteries, the corpora cavernosa, and the penile bulb for erectile function preservation.
Trial Details
NCT Number NCT04861194
Lead Sponsor UMC Utrecht
Conditions
(from sponsor)		 Prostate Cancer, Erectile Dysfunction Following Radiation Therapy
Related terms Prostatic Neoplasms
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov